Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Mid-range Performer
914.8500 -7.45 (-0.81%)
NSE Dec 18, 2025 15:31 PM
Volume: 388.9K
 

logo
Natco Pharma Ltd.
11 Aug 2022
914.85
-0.81%
buy
by ICICI Securities Limited
Target: 818
ICICI Securities Limited
Natco Pharma’s (Natco) Q1FY23 performance was ahead of our estimates led by ramp-up in Revlimid.
 
Number of MF schemes decreased from 47 to 19 in Sep 2025 qtr
More from Natco Pharma Ltd.
Recommended
Market closes flat as gains in financials & IT stocks offset losses in other sectors
Trendlyne Marketwatch | 18 Dec 2025, 04:19PM
Global aviation is growing, but competition is not
The Baseline | 18 Dec 2025, 01:35PM
Earnings Call Transcript - Q4FY20 for Natco Pharma
| 18 Jun 2020, 06:25PM